Skip to content
10-Q

Quarterly Report

SIGNPATH PHARMA, INC.

0001493152-15-005506

← back to feed
Filed
Nov 16, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 13, 2015 14.16M sh
Operating Cash Flow Q3 2015 · Sep 30, 2015 −$1.29M
Operating Cash Flow Q3 2015 · Sep 30, 2014 −$1.44M
Stockholders Equity Q3 2015 · Sep 30, 2015 $201.79K
Stockholders Equity Q3 2015 · Dec 31, 2014 $268.19K
Current Liabilities Q3 2015 · Sep 30, 2015 $303.46K
Current Liabilities Q3 2015 · Dec 31, 2014 $448K
Current Assets Q3 2015 · Sep 30, 2015 $505.25K
Current Assets Q3 2015 · Dec 31, 2014 $716.19K
Total Assets Q3 2015 · Sep 30, 2015 $505.25K
Total Assets Q3 2015 · Dec 31, 2014 $716.19K
Sga Expense Q3 2015 · Sep 30, 2015 $36.91K
Sga Expense Q3 2015 · Sep 30, 2015 $157.18K
Sga Expense restated Q3 2015 · Sep 30, 2014 $45.85K
Sga Expense Q3 2015 · Sep 30, 2014 $60.04K
Rd Expense Q3 2015 · Sep 30, 2015 $274.16K
Rd Expense Q3 2015 · Sep 30, 2015 $683.8K
Rd Expense Q3 2015 · Sep 30, 2014 $799.97K
Rd Expense Q3 2015 · Sep 30, 2014 $1.55M
Net Income Q3 2015 · Sep 30, 2015 −$477.1K
Net Income Q3 2015 · Sep 30, 2015 −$1.36M
Net Income Q3 2015 · Sep 30, 2014 −$982.79K
Net Income Q3 2015 · Sep 30, 2014 −$2.14M
Operating Income Q3 2015 · Sep 30, 2015 −$475.68K
Operating Income Q3 2015 · Sep 30, 2015 −$1.38M
Operating Income Q3 2015 · Sep 30, 2014 −$978.96K
Operating Income Q3 2015 · Sep 30, 2014 −$2.14M